Using physiologically based pharmacokinetic modelling for in silico-in vitro-in vivo extrapolation to predict chemical exposure

被引：0
|
作者：
Lawless, M. [1 ]
Zhou, H. [1 ]
Fraczkiewicz, G. [1 ]
机构：
[1] Simulat Plus, Lancaster, CA USA
来源：
TOXICOLOGY LETTERS | 2016年 / 258卷
关键词：
D O I：
10.1016/j.toxlet.2016.06.1484
中图分类号：
R99 [毒物学（毒理学）];
学科分类号：
100405 ;
摘要：
P05-016
引用
收藏
页码：S119 / S120
页数：2
相关论文
共 50 条
  • [21] Ethnic-Specific In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Approaches to Predict Cytochrome P450-Mediated Pharmacokinetics in the Chinese Population: Opportunities and Challenges
    Li, Guo-Fu
    Yu, Guo
    Liu, Hong-Xia
    Zheng, Qing-Shan
    CLINICAL PHARMACOKINETICS, 2014, 53 (02) : 197 - 202
  • [22] Development of physiologically based pharmacokinetic (PBPK) models for quantitative in vitro-in vivo extrapolations (QIVIVE)
    Punt, A.
    TOXICOLOGY LETTERS, 2022, 368 : S5 - S5
  • [23] Pharmacokinetic and Pharmacodynamic Analysis of Efavirenz Dose Reduction Using an In Vitro-In Vivo Extrapolation Model
    Siccardi, M.
    Almond, L.
    Schipani, A.
    Csajka, C.
    Marzolini, C.
    Wyen, C.
    Brockmeyer, N. H.
    Boffito, M.
    Owen, A.
    Back, D.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (04) : 494 - 502
  • [24] In Vivo-In Vitro-In Silico Pharmacokinetic Modelling in Drug Development Current Status and Future Directions
    Pelkonen, Olavi
    Turpeinen, Miia
    Raunio, Hannu
    CLINICAL PHARMACOKINETICS, 2011, 50 (08) : 483 - 491
  • [25] Understanding Receptor-Mediated Effects in Rainbow Trout: In Vitro-in Vivo Extrapolation Using Physiologically Based Toxicokinetic Models
    Brinkmann, Markus
    Eichbaum, Kathrin
    Buchinger, Sebastian
    Reifferscheid, Georg
    Thuy Bui
    Schaeffer, Andreas
    Hollert, Henner
    Preuss, Thomas G.
    ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2014, 48 (06) : 3303 - 3309
  • [26] Response to "Ethnic-Specific In Vitro-In Vivo Extrapolation and Physiologically Based Pharmacokinetic Approaches to Predict Cytochrome P450-Mediated Pharmacokinetics in Chinese Population: Opportunities and Challenges"
    Barter, Zoe E.
    Tucker, Geoffrey T.
    Rowland-Yeo, Karen
    CLINICAL PHARMACOKINETICS, 2014, 53 (02) : 203 - 203
  • [27] Evaluation of an integrated in vitro-in silico PBPK (physiologically based pharmacokinetic) model to provide estimates of human bioavailability
    Cai, HL
    Stoner, C
    Reddy, A
    Freiwald, S
    Smith, D
    Winters, R
    Stankovic, C
    Surendran, N
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 308 (1-2) : 133 - 139
  • [28] Analysis of the enhanced oral bioavailability of fenofibrate lipid formulations in fasted humans using an in vitro-in silico-in vivo approach
    Fei, Yang
    Kostewicz, Edmund S.
    Sheu, Ming-Thau
    Dressman, Jennifer B.
    EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2013, 85 (03) : 1274 - 1284
  • [29] In Vitro-In Vivo Extrapolation by Physiologically Based Kinetic Modeling: Experience With Three Case Studies and Lessons Learned
    Algharably, Engi Abdelhady
    Di Consiglio, Emma
    Testai, Emanuela
    Pistollato, Francesca
    Mielke, Hans
    Gundert-Remy, Ursula
    FRONTIERS IN TOXICOLOGY, 2022, 4
  • [30] Physiologically Based Pharmacokinetics Joined With In Vitro-In Vivo Extrapolation of ADME: A Marriage Under the Arch of Systems Pharmacology
    Rostami-Hodjegan, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2012, 92 (01) : 50 - 61
12345